Skip to content

Edwards Lifesciences

US · EW #442 by market cap Listed 1970
101.85 -2.03 -1.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Edwards Lifesciences

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Founded
1958
CEO
Mr. Bernard J. Zovighian
Employees
16,000
Headquarters
Irvine, California, United States of America
Fiscal year end
12-31
Website
edwards.com

Company profile

Exchange
US
Symbol
EW
Market-cap rank
#442
Listing date
1970-01-01
Market cap
58.56B
Float cap
58.38B
Shares out
575.00M
Float shares
573.23M

Sectors & themes

Medical Devices Global medical industry Regular Savings Plan Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.

Edwards Lifesciences discussion 0 comments

Add a comment